ProJenX Revenue and Competitors
Employee Data
- ProJenX has 7 Employees.
- ProJenX grew their employee count by 40% last year.
ProJenX's People
| Name | Title | Email/Phone |
|---|
ProJenX Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | N/A | 12 | 20% | N/A | N/A |
What Is ProJenX?
ProJenX is a clinical-stage biotechnology company with novel, targeted, brain-penetrant therapies to address neurodegenerative diseases, with an initial focus on ALS. ProJenX was created out of a long-term research collaboration between Project ALS and Columbia University to rapidly develop and commercialize its lead therapy candidate, prosetin, for people with ALS. At the heart of ProJenX’s discoveries is an innovative, patient-specific, cell-based discovery platform that can be leveraged for the creation of additional transformative neuroscience medicines.
keywords:N/A
N/A
Total Funding
7
Number of Employees
N/A
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | 0% | $1.4B |
#2 | $0.9M | 7 | -50% | N/A |
#3 | $0.1M | 7 | -22% | $17M |
#4 | $1.4M | 7 | 0% | N/A |
#5 | $0.1M | 7 | -22% | $8.7M |